SPL starpharma holdings limited
Add to My Watchlist 3.87% ! 9.4¢

Access to antivirals in Australia - recent study, page-3

  1. Starlink
    1,328 Posts.
    lightbulb Created with Sketch. 289
    clock Created with Sketch.
    07/10/24
    16:09
    Post #: 76012806
    yes BANNED from advertising or selling Viraleze with Astodrimer sodium in Australia as product not listed in any register on Australian Register of Therapeutic Goods ARTG

    your post is playing semantics
    SPL Price at posting: 9.7¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Galactica Drilling Program Complete as Blue Star Transitions to Commercial Production
right-arrow Created with Sketch.
NEWS Argenica Receives FDA Investigational New Drug Application Update
right-arrow Created with Sketch.
NEWS Anson Completes Maiden JORC Mineral Resources Estimate at Green River Lithium Project
right-arrow Created with Sketch.
WCE West Coast Silver Identifies Shallow High-Grade Mineralisation in Early Drilling
right-arrow Created with Sketch.
NEWS Vection Launches Algho AI Sign Language on AWS Marketplace Across Europe
right-arrow Created with Sketch.
NEWS Sunshine Intersects Further Shallow High-Grade Gold at Liontown
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.4¢ 		Change
0.004(3.87%) 		Mkt cap ! $39.31M
Open High Low Value Volume
9.0¢ 9.4¢ 9.0¢ $21.86K 237.3K

Buyers (Bids)

No. Vol. Price($)
2 120141 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 13999 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.